ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Rural prioritization may increase the impact of COVID-19 vaccines in a representative COVAX AMC country setting due to ongoing internal migration: A modeling study
This article has 7 authors:Reviewed by ScreenIT
-
Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences
This article has 20 authors:Reviewed by Review Commons, ScreenIT
-
Analysis of the Second COVID-19 Wave in India and the United Kingdom Using a Birth-Death Model
This article has 1 author:Reviewed by ScreenIT
-
COVID in Post Vaccinated individuals- Beacon of Light
This article has 6 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Integrative COVID-19 biological network inference with probabilistic core decomposition
This article has 7 authors:Reviewed by ScreenIT
-
A short plus long-amplicon based sequencing approach improves genomic coverage and variant detection in the SARS-CoV-2 genome
This article has 10 authors:Reviewed by ScreenIT
-
Temporal changes in mental response and prevention patterns, and their impact from uncertainty stress during the transition in China from the COVID-19 epidemic to sporadic infection
This article has 4 authors:Reviewed by ScreenIT
-
The accuracy of saliva versus nasopharyngeal and/or oropharyngeal samples for the detection of SARS-CoV-2 in children – A rapid systematic review and meta-analysis
This article has 6 authors:Reviewed by ScreenIT
-
Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19
This article has 9 authors:Reviewed by ScreenIT
-
Identification of SGLT2 inhibitor Ertugliflozin as a treatment for COVID-19 using computational and experimental paradigm
This article has 9 authors:Reviewed by ScreenIT